Definitive Healthcare Appoints Clay Ritchey as CEO
Definitive Healthcare (Nasdaq: DH) has appointed Clay Ritchey as its next CEO and board member effective September 8, 2026, succeeding Kevin Coop, who departed as CEO and director effective August 31, 2026 after roughly two years in the role. Ritchey was most recently CEO of healthcare master data management firm Verato and previously led Evariant through its acquisition by Healthgrades, with senior roles at Imprivata, Equinox Healthcare, Hill-Rom and Kronos. Chairman Jason Krantz framed the hire as a growth catalyst, citing Ritchey's track record of faster, durable and profitable growth and his conviction that AI is poised to reshape healthcare commercial intelligence.
Key figures
- Outgoing ceo tenure start
- June 2024
- Incoming ceo effective date
- 2026-09-08
- Outgoing ceo departure date
- 2026-08-31
- Incoming ceo experience years
- 25+
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.